A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

Recruiting

Phase 3

HBS-301A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

Sponsor:

Harmony Biosciences Management, Inc.

Code:

NCT07675135

Conditions

EDS

Cataplexy

Fatigue

Narcolepsy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

HBS-301

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-06. This information was provided to ClinicalTrials.gov by Harmony Biosciences Management, Inc. on 2026-06-30.